Políticas Médicas

Las políticas médicas son documentos que definen el reconocimiento de cubierta para tecnologías, procedimientos y tratamientos. Las declaraciones de necesidad médica en las políticas, sobre si una tecnología, procedimiento, tratamiento, suplido, equipo, medicamento u otro servicio mejora el resultado en la salud de la población para la cual dicha tecnología o tratamiento fue diseñado se basan en evidencia científica, estudios clínicos y opiniones profesionales de nuestros proveedores y de las organizaciones médicas reconocidas.

Cada documento desplegado en este sitio Web se provee con propósitos informativos solamente y no es una autorización, explicación de beneficios o un contrato. El recibir beneficios está sujeto a la satisfacción de todos los términos y condiciones de la cubierta. La tecnología médica cambia constantemente y nos reservamos el derecho de revisar y actualizar nuestras políticas periódicamente.

Tabla de Políticas Médicas

ID Título Revisión Descripción Acceso
11.003.040 Genetic Testing For Alzheimer Disease Nov 2025 Alzheimer disease (ad) is the most common cause of dementia in elderly patients. for late-onset ad, there is... Ver
11.003.042 Genetic Testing For Cardiac Ion Channelopathies Feb 2026 Genetic testing is available for individuals suspected of having cardiac ion channelopathies, including long... Ver
11.003.046 Genetic Testing For Fmr1 Variants (Including Fragile X Syndrome) Feb 2026 Fragile x syndrome (fxs) is the most common inherited form of mental disability and a known genetic cause of... Ver
11.003.047 Gene Expression-Based Assays For Cancers Of Unknown Primary May 2026 Cancers of unknown primary represent 3% to 4% of cancers diagnosed in the united states. these cancers are... Ver
11.003.048 Carrier Screening For Genetic Diseases Sep 2026 Carrier screening is performed to identify individuals at risk of having offspring with inherited recessive... Ver
11.003.049 Genetic Testing For Diagnosis And Management Of Mental Health Conditions Sep 2026 Individual genes have been shown to be associated with the risk of psychiatric disorders and specific aspects... Ver
11.003.050 Genetic Testing For Epilepsy Mar 2026 Epilepsy is a disorder characterized by unprovoked seizures. it is a heterogeneous condition that encompasses... Ver
11.003.051 Gene Expression Profiling And Protein Biomarkers For Prostate Cancer Management Aug 2026 Gene expression profile analysis and protein biomarkers have been proposed as a means to risk-stratify... Ver
11.003.052 Molecular Markers In Fine Needle Aspirates Of The Thyroid Sep 2026 To determine which patients need thyroid resection, many physicians will perform a cytologic examination of... Ver
11.003.053 Whole Exome And Whole Genome Sequencing For Diagnosis Of Genetic Disorders Feb 2026 Whole exome sequencing (wes) sequences the portion of the genome that contains protein-coding dna, while... Ver
11.003.056 Genetic Testing For A Thalassemia Sep 2026 Alpha-thalassemia represents a group of clinical syndromes of varying severity characterized by hemolytic... Ver
11.003.057 Genetic Testing For Fanconi Anemia Jan 2026 Fanconi anemia (fa) is an inherited disorder characterized by congenital abnormalities, bone marrow failure,... Ver
11.003.059 Genetic Testing For Hereditary Pancreatitis Mar 2026 ... Ver
11.003.060 Genetic Testing For Flt3, Npm1, And Cebpa Variants In Cytogenetically Normal Acute Myeloid Leukemia Feb 2026 Treatment of acute myeloid leukemia (aml) is based on risk stratification, primarily related to age and tumor... Ver
11.003.062 General Approach To Genetic Testing Jan 2026 Commercially available genetic tests can perform a host of functions, such as providing a guided intervention... Ver
11.003.063 Bcr-Abl1 Testing In Chronic Myelogenous Leukjemia And Acute Lymphoblastic Leukemia Nov 2025 In the treatment of philadelphia chromosome-positive leukemias, various nucleic acid-based laboratory methods... Ver
11.003.064 Genetic Cancer Susceptibility Panels Using Next Generation Sequencing Sep 2026 Commercially available cancer susceptibility gene panels can test for multiple variants associated with a... Ver
11.003.066 Genetic Testing For Duchenne And Becker Muscular Dystrophy Apr 2026 Variants in the duchenne muscular dystrophy (dmd) gene, which encodes the protein dystrophin, may result in a... Ver
11.003.067 Genotype-Guided Warfarin Dosing Jul 2026 Using information about an individual's genotype may help in guiding warfarin dosing and could reduce... Ver
11.003.068 Genetic Testing For The Diagnosis Of Inherited Peripheral Neuropathies Feb 2026 The inherited peripheral neuropathies are a heterogeneous group of diseases that may be inherited in an... Ver